1.7850 +0.01 (0.85%)
After hours: 4:38PM EDT
|Bid||1.7700 x 28000|
|Ask||1.8000 x 3000|
|Day's range||1.7400 - 1.7900|
|52-week range||0.7500 - 2.4000|
|Beta (5Y monthly)||1.66|
|PE ratio (TTM)||N/A|
|Earnings date||06 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.00|
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank (SVB). The loan facility provides the Company with access to non-dilutive financial resources to support the imetelstat development program, as well as working capital and general corporate purposes.
Geron (GERN) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.